Arcutis Biotherapeutics, Inc. short interest in 2024
In 2024, Arcutis Biotherapeutics, Inc.'s disclosed short interest ran from 22.07% of shares outstanding on 12 Jan 2024 to 17.91% on 31 Dec 2024, a change of -4.16 percentage points. The year's high was 26.87% on 14 Jun 2024 and its low 15.49% on 15 Mar 2024, averaging 21.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.13 days on 13 Sep 2024. Full history: Arcutis Biotherapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 22.07% (12 Jan 2024)
- End of year
- 17.91% (31 Dec 2024)
- Change
- -4.16 pp
- High
- 26.87% (14 Jun 2024)
- Low
- 15.49% (15 Mar 2024)
- Average
- 21.18%
- Highest days to cover
- 18.13 (13 Sep 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 22.07% | 3.25 | |
| 31 Jan 2024 | 17.78% | 3.05 | |
| 15 Feb 2024 | 17.95% | 3.90 | |
| 29 Feb 2024 | 16.30% | 2.44 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 15.49% | 3.14 | |
| 28 Mar 2024 | 19.89% | 5.78 | |
| 15 Apr 2024 | 20.31% | 6.17 | |
| 30 Apr 2024 | 22.40% | 9.69 | |
| 15 May 2024 | 22.90% | 6.08 | 10-Q filed, results (8-K) |
| 31 May 2024 | 25.45% | 8.35 | |
| 14 Jun 2024 | 26.87% | 10.94 | |
| 28 Jun 2024 | 22.04% | 6.12 | |
| 15 Jul 2024 | 23.41% | 7.67 | |
| 31 Jul 2024 | 22.67% | 11.61 | |
| 15 Aug 2024 | 20.36% | 9.52 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 21.12% | 10.62 | |
| 13 Sep 2024 | 21.27% | 18.13 | |
| 30 Sep 2024 | 23.21% | 12.03 | |
| 15 Oct 2024 | 24.01% | 17.77 | |
| 31 Oct 2024 | 23.74% | 16.71 | |
| 15 Nov 2024 | 21.37% | 8.67 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 20.10% | 12.77 | |
| 13 Dec 2024 | 19.75% | 12.55 | |
| 31 Dec 2024 | 17.91% | 9.10 |
See also: Arcutis Biotherapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.